In contrast, 72/155 of MM patient samples (46.5%) were DSG2+ in the E‐MTAB‐363 dataset and 39/133 (29.3%) samples were DSG2+ in the E‐GEOD‐16122 dataset. This evidence concerns the gene DSG2 and Miyoshi myopathy.